In this study, we revealed that LAT1 expression correlated with disease lymphoma grade and the LAT1 expression level inversely correlated with patient survival, suggesting that LAT1 can be used as a prognostic marker for NHL. Here, SLC7A5 is linked to non-Hodgkin lymphoma.